EMulate Therapeutics Announces Brett Greene, Veteran in the Psychedelic and Cannabinoid Biotechnology Industry, as a Company Advisor

BELLEVUE, Wash.–(BUSINESS WIRE)–EMulate Therapeutics, Inc. (“EMulate” or the “Company”) is excited to announce that Brett J. Greene will be a new advisor to the Company. He will focus his attention on the Company’s work in mental health therapeutics. Brett is a proven and recognized entrepreneur and business founder in the psychedelic and cannabinoid biotechnology industry. He began his career at Northeastern University’s Center for Drug Discovery where, as research administrator, he co-manag

Recent Articles